Abstract
AbstractRadiotherapy (RT) is a widely used treatment with strong therapeutic effects, but overcoming challenges related to hypoxia-induced tumor resistance and ineffective antitumor immune responses is crucial for optimal outcomes. In this study, we developed a versatile nanosystem using mesoporous silica nanoparticles (MSNs), R837, and a small quantity of manganese peroxide (Mn/ZnO2). The synthesized MSN@R837-Mn/ZnO2 nanoparticles exhibited precise tumor targeting and accumulation, controlled drug release under acidic conditions, and increased sensitivity in magnetic resonance imaging. These attributes collectively augmented the therapeutic efficacy of RT by alleviating hypoxia and immunosuppression. Tumor cells treated with RT combined with these nanoparticles displayed reduced oxidative stress, alleviated hypoxia, and normalized blood vessel formation. Notably, all mice in the RT + PD-1 + MSN@R837-Mn/ZnO2 group achieved complete tumor regression with extended survival. Safety assessments confirmed the absence of MSN@R837-Mn/ZnO2 toxicity, highlighting its potential as a promising approach with dual functionality for the diagnostic imaging and treatment of cancer.
Funder
National Natural Science Foundation of China
Outstanding Youth Foundation of Jiangsu Province of China
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Huang, R. X. & Zhou, P. K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct. Target. Ther. 5, 60 (2020).
2. Shaowen, X. & Shanwen, Z. New advances in clinical treatment of radiation oncology. Sci. Technol. Rev. 32, 37–41 (2014).
3. He, J. et al. Basic guidelines of quality control for radiotherapy. Chin. J. Radiat. Oncol. 27, 335–342 (2018).
4. Zschaeck, S. et al. Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 149, 189–196 (2020).
5. Brown, J. M. Radiation damage to tumor vasculature initiates a program that promotes tumor recurrences. Int. J. Radiat. Oncol. Biol. Phys. 108, 734–744 (2020).